West Pharmaceutical Services Income from Continuous Operations 2010-2024 | WST

West Pharmaceutical Services income from continuous operations for the twelve months ending December 31, 2024 was $0.493B, a 16.97% decline year-over-year.

  • West Pharmaceutical Services annual income from continuous operations for 2024 was $0.493B, a 16.97% decline from 2023.
  • West Pharmaceutical Services annual income from continuous operations for 2023 was $0.593B, a 1.28% increase from 2022.
  • West Pharmaceutical Services annual income from continuous operations for 2022 was $0.586B, a 11.47% decline from 2021.

West Pharmaceutical Services Income from Continuous Operations 2010-2024 | WST

  • West Pharmaceutical Services annual income from continuous operations for 2024 was $0.493B, a 16.97% decline from 2023.
  • West Pharmaceutical Services annual income from continuous operations for 2023 was $0.593B, a 1.28% increase from 2022.
  • West Pharmaceutical Services annual income from continuous operations for 2022 was $0.586B, a 11.47% decline from 2021.
Related Stocks
Company NameMarket
Cap
McKesson (MCK)$75.5B
Becton Dickinson (BDX)$65.3B
Cardinal Health (CAH)$30.6B
Straumann Holding AG (SAUHY)$23.7B
Labcorp (LH)$20.7B
Cooper (COO)$17.3B
Align Technology (ALGN)$15.1B
Henry Schein (HSIC)$9.7B
Merit Medical Systems (MMSI)$6.2B
DENTSPLY SIRONA (XRAY)$3.8B
Patterson (PDCO)$2.7B
CONMED (CNMD)$1.9B
STAAR Surgical (STAA)$876M
Lifevantage (LFVN)$230M
Pro-Dex (PDEX)$112M